BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

643 related articles for article (PubMed ID: 14767477)

  • 1. A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways.
    Adriaenssens E; Mougel A; Goormachtigh G; Loing E; Fafeur V; Auriault C; Coll J
    Oncogene; 2004 Apr; 23(15):2681-93. PubMed ID: 14767477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of tumor necrosis factor-induced phenotypes by short intracellular versions of latent membrane protein-1.
    Ndour PA; Ouk TS; Brocqueville G; Mougel A; Vanhecke E; Feuillard J; Coll J; Adriaenssens E
    Cell Signal; 2010 Feb; 22(2):303-13. PubMed ID: 19796681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1).
    Eliopoulos AG; Young LS
    Oncogene; 1998 Apr; 16(13):1731-42. PubMed ID: 9582021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.
    Eliopoulos AG; Stack M; Dawson CW; Kaye KM; Hodgkin L; Sihota S; Rowe M; Young LS
    Oncogene; 1997 Jun; 14(24):2899-916. PubMed ID: 9205097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latent membrane protein 1 associated signaling pathways are important in tumor cells of Epstein-Barr virus negative Hodgkin's disease.
    Knecht H; Berger C; McQuain C; Rothenberger S; Bachmann E; Martin J; Esslinger C; Drexler HG; Cai YC; Quesenberry PJ; Odermatt BF
    Oncogene; 1999 Nov; 18(50):7161-7. PubMed ID: 10597317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterodimer formation between c-Jun and Jun B proteins mediated by Epstein-Barr virus encoded latent membrane protein 1.
    Song X; Tao YG; Deng XY; Jin X; Tan YN; Tang M; Wu Q; Lee LM; Cao Y
    Cell Signal; 2004 Oct; 16(10):1153-62. PubMed ID: 15240010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus latent membrane protein-1 (LMP1) signalling is distinct from CD40 and involves physical cooperation of its two C-terminus functional regions.
    Floettmann JE; Eliopoulos AG; Jones M; Young LS; Rowe M
    Oncogene; 1998 Nov; 17(18):2383-92. PubMed ID: 9811470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional analysis of the mutated Epstein-Barr virus oncoprotein LMP1(69del): implications for a new role of naturally occurring LMP1 variants.
    Larcher C; Bernhard D; Schaadt E; Adler B; Ausserlechner MJ; Mitterer M; Huemer HP
    Haematologica; 2003 Dec; 88(12):1324-35. PubMed ID: 14687985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus core protein enhances FADD-mediated apoptosis and suppresses TRADD signaling of tumor necrosis factor receptor.
    Zhu N; Ware CF; Lai MM
    Virology; 2001 May; 283(2):178-87. PubMed ID: 11336543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pursuing different 'TRADDes': TRADD signaling induced by TNF-receptor 1 and the Epstein-Barr virus oncoprotein LMP1.
    Kieser A
    Biol Chem; 2008 Oct; 389(10):1261-71. PubMed ID: 18713013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2.
    Eliopoulos AG; Blake SM; Floettmann JE; Rowe M; Young LS
    J Virol; 1999 Feb; 73(2):1023-35. PubMed ID: 9882303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus latent membrane protein 1 modulates epidermal growth factor receptor promoter activity in a nuclear factor kappa B-dependent manner.
    Tao YG; Tan YN; Liu YP; Song X; Zeng L; Gu HH; Tang M; Li W; Yi W; Cao Y
    Cell Signal; 2004 Jul; 16(7):781-90. PubMed ID: 15115657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A fusion of the EBV latent membrane protein-1 (LMP1) transmembrane domains to the CD40 cytoplasmic domain is similar to LMP1 in constitutive activation of epidermal growth factor receptor expression, nuclear factor-kappa B, and stress-activated protein kinase.
    Hatzivassiliou E; Miller WE; Raab-Traub N; Kieff E; Mosialos G
    J Immunol; 1998 Feb; 160(3):1116-21. PubMed ID: 9570524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of DNA methyltransferase 1 by EBV LMP1 Involves c-Jun NH(2)-terminal kinase signaling.
    Tsai CL; Li HP; Lu YJ; Hsueh C; Liang Y; Chen CL; Tsao SW; Tse KP; Yu JS; Chang YS
    Cancer Res; 2006 Dec; 66(24):11668-76. PubMed ID: 17178861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus (EBV) latent membrane protein-1 down-regulates tumor necrosis factor-alpha (TNF-alpha) receptor-1 and confers resistance to TNF-alpha-induced apoptosis in T cells: implication for the progression to T-cell lymphoma in EBV-associated hemophagocytic syndrome.
    Chuang HC; Lay JD; Chuang SE; Hsieh WC; Chang Y; Su IJ
    Am J Pathol; 2007 May; 170(5):1607-17. PubMed ID: 17456766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latent membrane protein 1 is critical for efficient growth transformation of human B cells by epstein-barr virus.
    Dirmeier U; Neuhierl B; Kilger E; Reisbach G; Sandberg ML; Hammerschmidt W
    Cancer Res; 2003 Jun; 63(11):2982-9. PubMed ID: 12782607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cytoplasmic amino-terminus of the Latent Membrane Protein-1 of Epstein-Barr Virus: relationship between transmembrane orientation and effector functions of the carboxy-terminus and transmembrane domain.
    Coffin WF; Erickson KD; Hoedt-Miller M; Martin JM
    Oncogene; 2001 Aug; 20(38):5313-30. PubMed ID: 11536044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain.
    Huen DS; Henderson SA; Croom-Carter D; Rowe M
    Oncogene; 1995 Feb; 10(3):549-60. PubMed ID: 7845680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unique signaling properties of CTAR1 in LMP1-mediated transformation.
    Mainou BA; Everly DN; Raab-Traub N
    J Virol; 2007 Sep; 81(18):9680-92. PubMed ID: 17626074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LMP1 structure and signal transduction.
    Eliopoulos AG; Young LS
    Semin Cancer Biol; 2001 Dec; 11(6):435-44. PubMed ID: 11669605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.